000			01719 a2200481 4500
005			20250513030940.0
264		0	_c19940718
008			199407s 0 0 eng d
022			_a0250-7005
040			_aNLM _beng _cNLM
100	1		_aGebbia, V
245	0	0	_aA prospective randomized trial of thymopentin versus granulocyte--colony stimulating factor with or without thymopentin in the prevention of febrile episodes in cancer patients undergoing highly cytotoxic chemotherapy. _h[electronic resource]
260			_bAnticancer research _c
300			_a731-4 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aEndometrial Neoplasms _xdrug therapy
650	0	4	_aFemale
650	0	4	_aFever _xprevention & control
650	0	4	_aGranulocyte Colony-Stimulating Factor _xadverse effects
650	0	4	_aHead and Neck Neoplasms _xdrug therapy
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMycoses _xepidemiology
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aNeutropenia _xepidemiology
650	0	4	_aOvarian Neoplasms _xdrug therapy
650	0	4	_aProspective Studies
650	0	4	_aStomach Neoplasms _xdrug therapy
650	0	4	_aThymopentin _xadverse effects
700	1		_aValenza, R
700	1		_aTesta, A
700	1		_aCannata, G
700	1		_aBorsellino, N
700	1		_aGebbia, N
773	0		_tAnticancer research _gvol. 14 _gno. 2B _gp. 731-4
999			_c7516114 _d7516114